In vitro and in vivo evaluations of a radioiodinated thymidine phosphorylase inhibitor as a tumor diagnostic agent for angiogenic enzyme imaging
Authors:
- Songji ZhaoSZSongji Zhao
- Masayuki TakahashiMTMasayuki Takahashi
- Ken-Ichi NishijimaKNKen-Ichi Nishijima
- Yuji KugeYKYuji Kuge
- Nagara TamakiNTNagara Tamaki
- Koh-Ichi SekiKSKoh-Ichi Seki
- Kazue OhkuraKOKazue Ohkura
- 1 May 2010
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 37 (4) , 427-432
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- Evaluation of 5′-deoxy-5′-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activityNuclear Medicine and Biology, 2007
- Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancersNuclear Medicine and Biology, 2004
- Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancerHuman Pathology, 2002
- Thymidine phosphorylase as a target for imaging and therapy with thymine analogsCancer Chemotherapy and Pharmacology, 2001
- The role of thymidine phosphorylase expression in the invasiveness of gastric carcinomaCancer, 2000
- Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma.Journal of Clinical Oncology, 1997
- The activity and expression of thymidine phosphorylase in human solid tumoursEuropean Journal of Cancer, 1996
- Angiogenic activity of enzymesNature, 1994
- Angiogenic factorNature, 1992
- Enzymatic formation of 5-fluorouracil from 1-(tetrahydro-2-furanyl)-5-fluorouracil (tegafur) in human tumor tissues.Chemical and Pharmaceutical Bulletin, 1981